Siga Technologies (SIGA)
(Delayed Data from NSDQ)
$8.79 USD
+0.15 (1.74%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $8.79 0.00 (0.00%) 5:58 PM ET
1-Strong Buy of 5 1
B Value C Growth F Momentum B VGM
Brokerage Reports
0 items in cart
Siga Technologies Inc. [SIGA]
Reports for Purchase
Showing records 1 - 20 ( 76 total )
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for SIGA 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Siga Technologies Inc.
Industry: Medical - Drugs
International momentum building towards year-end
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S
Company: Siga Technologies Inc.
Industry: Medical - Drugs
EU gateway to tap into new international orders
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Notable CMO appointment to position for growth
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Second quarter as expected, onward to H223
Provider: Edison Investment Research Limited
Analyst: AATKAR A
Company: Siga Technologies Inc.
Industry: Medical - Drugs
US exercised (stockpile) options are key catalysts
Provider: Edison Investment Research Limited
Analyst: AATKAR A
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Diamond in the rough amid macro weakness
Provider: Edison Investment Research Limited
Analyst: AATKAR A
Company: Siga Technologies Inc.
Industry: Medical - Drugs
US stockpiles front and center in Q1 and FY23
Provider: Edison Investment Research Limited
Analyst: Research Department
Company: Siga Technologies Inc.
Industry: Medical - Drugs
US stockpiles front and center in Q1 and FY23
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Solid results marked by revenue diversification
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Solid Q322, underpinned by international traction
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S
Company: Siga Technologies Inc.
Industry: Medical - Drugs
TPOXX trials launched in treating monkeypox
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Second contract win from the US DoD in 2022
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Monkeypox concern drives international TPOXX win
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S
Company: Siga Technologies Inc.
Industry: Medical - Drugs
Company: Siga Technologies Inc.
Industry: Medical - Drugs
BARDA exercises first option for IV TPOXX
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S